Marco Ferretti
Director/Board Member at CONVERGENZE S.P.A. SOCIETÀ BENEFIT
Profile
Marco Ferretti is currently the Chairman of MAR.TE.
Scarl, an Independent Director at Convergenze SpA Società Benefit, and a Partner at Nextgen Srl (Naples), E.Built Srl, and Epi-C Srl.
He is also a Director & Professor at Universita degli Studi di Napoli Parthenope.
Ferretti holds a doctorate degree from the University of Padua, an undergraduate degree from Università degli Studi di Napoli Federico II, and a graduate degree from MIT Sloan School of Management.
Marco Ferretti active positions
Companies | Position | Start |
---|---|---|
CONVERGENZE S.P.A. SOCIETÀ BENEFIT | Director/Board Member | 2020-10-15 |
Universita degli Studi di Napoli Parthenope | Director/Board Member | - |
MAR.TE. Scarl | Chairman | 2012-12-31 |
Nextgen Srl (Naples)
Nextgen Srl (Naples) BiotechnologyHealth Technology Nextgen Srl is a biotechnology company based in Naples, Italy. The Italian company specializes in researching and developing drugs to treat scleroderma. | Corporate Officer/Principal | - |
E.Built Srl | Corporate Officer/Principal | - |
Epi-C Srl | Corporate Officer/Principal | - |
Training of Marco Ferretti
University of Padua | Doctorate Degree |
Università degli Studi di Napoli Federico II | Undergraduate Degree |
MIT Sloan School of Management | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
CONVERGENZE S.P.A. SOCIETÀ BENEFIT | Communications |
Private companies | 4 |
---|---|
MAR.TE. Scarl | |
Nextgen Srl (Naples)
Nextgen Srl (Naples) BiotechnologyHealth Technology Nextgen Srl is a biotechnology company based in Naples, Italy. The Italian company specializes in researching and developing drugs to treat scleroderma. | Health Technology |
E.Built Srl | |
Epi-C Srl |
- Stock Market
- Insiders
- Marco Ferretti